Barely Significant
← all excerpts

Current evidence on the use of anakinra in COVID-19.

Int Immunopharmacol · 2022 · PMC9296834 · PMID 35905562

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.